Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesWomens ImagingCEM identifies nipple tumor involvement in breast cancer patientsCEM achieved high specificity and positive predictive value for indicating nipple involvement, researchers reported.MRIMRI shows myelination patterns across early childhoodCTDegree of net water uptake on CT helps predict EVT treatment efficacyWomens ImagingBreast imaging reads are shifting from generalists to specialistsSponsor ContentJoin Us!